Transplantation of fetal midbrain dopamine progenitors into a rodent model of Parkinson's disease

Methods in Molecular Biology

Volumn 1059, Issue , 2013, Pages 169-180

  Thompson, Lachlan H ^a   Parish, Clare L ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Cell therapy; Mesencephalon; Micro transplantation; Movement disorders; Regeneration

Indexed keywords

DOPAMINE; OXIDOPAMINE;

AQUEOUS SOLUTION; ARTICLE; CELL SUSPENSION; CELL VIABILITY; CIRCLING BEHAVIOR; CONNECTIVE TISSUE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; EMBRYO; FOREBRAIN; MESENCEPHALON; MOUSE; NEURAL STEM CELL TRANSPLANTATION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PETRI DISH; PRIORITY JOURNAL; RAT;

ANIMALIA; RODENTIA;

EID: 84934442392     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-574-3_15     Document Type: Article

References (17)

1. Thompson WG (1890) Successful brain grafting. Science 16:78
2. Perlow MJ et al (1979) Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204:643
3. Bjorklund A, Stenevi U (1979) Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 177:555
4. Bjorklund A, Schmidt RH, Stenevi U (1980) Functional reinnervation of the neostriatum in the adult rat by use of intraparenchymal grafting of dissociated cell suspensions from the substantia nigra. Cell Tissue Res 212:39
5. Bjorklund A et al (1983) Intracerebral grafting of neuronal cell suspensions. I. Introduction and general methods of preparation. Acta Physiol Scand Suppl 522:1
6. Nikkhah G et al (1994) Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res 633:133
7. Lindvall O, Hagell P (2000) Clinical observations after neural transplantation in Parkinson's disease. Prog Brain Res 127:299
8. Winkler C, Kirik D, Bjorklund A (2005) Cell transplantation in Parkinson's disease: How can we make it work? Trends Neurosci 28:86
9. Torres EM et al (2007) Improved survival of young donor age dopamine grafts in a rat model of Parkinson's disease. Neuroscience 146:1606
10. Bjorklund A, Dunnett SB (1994) Functional neural transplantation II. Novel cell therapies for cns disorders. Progress in brain research, vol 127. Elsevier, New York
11. Dunnett SB, Boulton AA, Baker GB (2000) Neural transplantation methods. In: Wolfgang W (ed) Neuromethods, vol 36. Humana, Totowa, p 576
12. Carlsson T et al (2007) Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease. J Neurosci 27:8011
13. Bjorklund A et al (1983) Intracerebral grafting of neuronal cell suspensions. VII. Recovery of choline acetyltransferase activity and acetylcholine synthesis in the denervated hippocampus reinnervated by septal suspension implants. Acta Physiol Scand Suppl 522:59
14. Kirik D, Rosenblad C, Bjorklund A (1998) Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 152:259
15. Lee CS, Sauer H, Bjorklund A (1996) Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat. Neuroscience 72:641
16. Iancu R et al (2005) Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. Behav Brain Res 162:1
17. Lundblad M et al (2004) A model of L-DOPAinduced dyskinesia in 6-hydroxydopamine lesioned mice: Relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis 16:110